Ticker Scorecard - BVS Basics Company: Bioventus Inc. IPO Date: February 11, 2021 Sector: Healthcare Industry: Medical Devices Market Cap: $654.33M Activated in VL: True Average Daily Range Avg Daily Range: $0.24 | 3.29% Avg Daily Range (30 D): $0.17 | 1.76% Avg Daily Range (90 D): $0.27 | 2.57% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .22M Avg Daily Volume (90 D): .27M Trade Size Avg Trade Size (Sh.): 103 Avg Trade Size (Sh.) (30 D): 52 Avg Trade Size (Sh.) (90 D): 53 Institutional Trades Total Inst.Trades: 154 Avg Inst. Trade: $1.5M Avg Inst. Trade (30 D): $.69M Avg Inst. Trade (90 D): $1.12M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.83M Avg Closing Trade (30 D): $.58M Avg Closing Trade (90 D): $1.07M Avg Closing Volume: 200.25K     News Nov 26, 2024 @ 4:00 PM Osteoarthritis Therapeutics Market Size to Reach U... Source: Precedence Research Oct 4, 2024 @ 9:52 AM U.S. Osteoarthritis Injectables Market Analysis 20... Source: Researchandmarkets.Com Sep 24, 2024 @ 4:23 PM First September Gains in 5 Years? Buy 3 Breakout S... Source: Zacks Sep 5, 2024 @ 10:00 AM Pseudarthrosis Treatment Market is Projected to Re... Source: Fact.Mr Sep 3, 2024 @ 8:29 PM Corcept Shares Rise More Than 45% in Six Months: H... Source: Zacks Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.6 $-.07 $-.37 Diluted EPS $-.6 $-.07 $-.37 Revenue $ 555.06M $ 138.96M $ 151.22M Gross Profit $ 371.87M $ 93.55M $ 103.64M Net Income / Loss $ -51.17M $ -5.42M $ -32.11M Operating Income / Loss $ -18.8M $ 4.07M $ -29.37M Cost of Revenue $ 183.19M $ 45.41M $ 47.58M Net Cash Flow $ 16.25M $ 11.08M $ 6.82M PE Ratio